Galapagos
Employee Participants0
Total Rating0
Revenue$0
Developer of small molecule medicines using novel modes of action created to revolutionize existing treatment paradigms. The company is engaged in the discovery and development of small molecules and antibodies that inhibit rheumatoid arthritis, cystic fibrosis, inflammation and other targets, restore the balance and thereby positively influence the course of the disease, enabling patients to address the root cause of the disease rather than just treating the symptoms. Read More
0/100